MetLife Investment Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,150
| Closed | -$799K | – | 3031 |
|
|
2023
Q1 | $799K | Buy |
33,150
+2,366
| +8% | +$57K | 0.01% | 1352 |
|
|
2022
Q4 | $325K | Hold |
30,784
| – | – | ﹤0.01% | 1916 |
|
|
2022
Q3 | $139K | Buy |
30,784
+21,876
| +246% | +$98.4K | ﹤0.01% | 2507 |
|
|
2022
Q2 | $35.6K | Sell |
8,908
-23,508
| -73% | -$94K | ﹤0.01% | 2823 |
|
|
2022
Q1 | $237K | Buy |
32,416
+25,003
| +337% | +$183K | ﹤0.01% | 2253 |
|
|
2021
Q4 | $41.7K | Sell |
7,413
-13,272
| -64% | -$74.6K | ﹤0.01% | 2469 |
|
|
2021
Q3 | $132K | Buy |
20,685
+12,586
| +155% | +$80.6K | ﹤0.01% | 2312 |
|
|
2021
Q2 | $68.3K | Sell |
8,099
-13,497
| -62% | -$114K | ﹤0.01% | 2417 |
|
|
2021
Q1 | $227K | Buy |
21,596
+1,969
| +10% | +$20.7K | ﹤0.01% | 1988 |
|
|
2020
Q4 | $332K | Hold |
19,627
| – | – | ﹤0.01% | 1701 |
|
|
2020
Q3 | $252K | Hold |
19,627
| – | – | ﹤0.01% | 1720 |
|
|
2020
Q2 | $277K | Buy |
+19,627
| New | +$277K | ﹤0.01% | 1706 |
|